Header cover image

Investing Ideas
/
Global Pure Equity Growth

Global Pure Equity Growth

Results

181

0 new

Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.

181 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MX1 Micro-X	AU$0.071	31.5%	-40.8%	AU$40.7m	n/a	PS2.7x	E86.1%	n/a	Healthcare
	EYE Nova Eye Medical	AU$0.17	-5.4%	-7.9%	AU$40.1m	n/a	PS1.7x	E102.3%	n/a	Healthcare
	EYE Nova Eye Medical	AU$0.17	-5.4%	-7.9%	AU$40.1m	n/a	PS1.7x	E102.3%	n/a	Healthcare
	ENRAD Enrad	SEK 11.40	-24.0%	254.0%	SEK 278.3m	SEK 9.00	PE91.2x	E49.9%	n/a	Capital Goods
	BIOVIC B Biovica International	SEK 2.61	0%	-64.0%	SEK 235.8m	SEK 6.20	PS32.6x	E78.5%	n/a	Pharmaceuticals & Biotech
	9II Biovica International	SEK 0.20	-1.2%	-66.0%	SEK 231.7m	n/a	PS32x	E78.5%	n/a	Pharmaceuticals & Biotech
	3MM Advicenne	€1.90	0%	n/a	€11.4m	€10.74	PS3.3x	E47.4%	n/a	Pharmaceuticals & Biotech
	NEWBRY Newbury Pharmaceuticals	SEK 3.28	10.8%	-8.6%	SEK 79.6m	SEK 8.00	PS4.3x	E116.2%	n/a	Pharmaceuticals & Biotech
	P52 Newbury Pharmaceuticals	SEK 0.21	7.8%	-18.9%	SEK 79.6m	n/a	PS4.3x	E116.2%	n/a	Pharmaceuticals & Biotech
	ADR Adherium	AU$0.014	16.7%	-76.7%	AU$9.9m	n/a	PS10.8x	E73.7%	n/a	Healthcare
	ADR Adherium	AU$0.012	-14.3%	-80.0%	AU$9.1m	n/a	PS10.8x	E73.7%	n/a	Healthcare
	SCOL Scandion Oncology	SEK 0.14	0.7%	-90.6%	SEK 33.6m	n/a	PB0.7x	E75.3%	n/a	Pharmaceuticals & Biotech
	8VY Scandion Oncology	SEK 0.012	3.4%	n/a	SEK 33.6m	n/a	PB0.7x	E75.3%	n/a	Pharmaceuticals & Biotech

Page 8 of 8